SCHEMBL10669262

SCHEMBL10669262

CNc1nc(C)c(-c2sc(NC)nc2C)s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.56
CDK2 P24941 9/20 0.43
CDK4 P11802 5/20 0.43
CCNA2 P20248 5/20 0.43
PLK1 P53350 1/20 0.43
ALDH1A1 P00352 3/20 0.41
NFKB1 P19838 3/20 0.41
NFKB2 Q00653 3/20 0.41
RELA Q04206 3/20 0.41
MAPT P10636 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
GAA P10253 1/20 0.41
JUN P05412 2/20 0.40
KDM4E B2RXH2 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CDK9 P50750 7/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9965751 0.79
SCHEMBL924920 0.78 ALDH1A1 (0.51) KMT2ACDK2CDK4CCNA2PLK1
SCHEMBL18774053 0.75
SCHEMBL14489682 0.75
SCHEMBL29941155 0.74 CDK2 (0.53) KMT2ACDK2CDK4CCNA2PLK1
SCHEMBL924644 0.74 CDK2 (0.50) KMT2ACDK2CDK4CCNA2PLK1
SCHEMBL925797 0.73 CYP3A4 (0.51) KMT2ACDK2CDK4CCNA2PLK1
SCHEMBL4169064 0.72 CDK2 (0.68) CDK2CDK4CCNA2PLK1MAPT
SCHEMBL11916724 0.72 KMT2A (0.48) KMT2ACDK2CDK4CCNA2ALDH1A1
SCHEMBL19457067 0.72 TMIGD3 (0.51) KMT2ACDK2CDK4CCNA2PLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4735957-A ANTIULCER AGENTS, CARDIOTONIC AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-04-05 US disclosed
US-4649146-A ANTIULCER FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-03-10 US disclosed
EP-0117082-A2 Thiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-08-29 EP disclosed